Ryerson (RYI)
(Real Time Quote from BATS)
$21.96 USD
-0.45 (-2.01%)
Updated Jun 10, 2024 03:57 PM ET
After-Market: $21.96 0.00 (0.00%) 4:12 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
RYI 21.96 -0.45(-2.01%)
Will RYI be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for RYI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RYI
Ryerson's (RYI) Q4 Earnings Beat, Revenues Miss Estimates
Ryerson Holding (RYI) to Report Q4 Earnings: What's in the Offing?
RYI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Ryerson Holding (RYI) Suffers a Larger Drop Than the General Market: Key Insights
Ryerson Holding (RYI) Rises Higher Than Market: Key Facts
Ryerson Holding (RYI) Advances While Market Declines: Some Information for Investors
Other News for RYI
Radius Recycling: An Attractive, But Volatile, Play On A Cleaner Future
Oppenheimer Keeps Their Buy Rating on Viracta Therapeutics (VIRX)
Wall Street Breakfast: The Week Ahead
July 19th Options Now Available For Ryerson Holding (RYI)
Underpriced Stocks: 3 Hidden Gems Worth Snagging Now